| Blood coagulation and fibrinolytic activity in hypothyroidism C Erem, H Kavgaci, HÖ Ersöuz, A Hacihasanoglu, K Ukinç, SS Karti, ... International Journal of Clinical Practice 57 (2), 78-81, 2003 | 116 | 2003 |
| Mediastinal lymph nodes: Assessment with diffusion‐weighted MR imaging P Koşucu, C Tekinbaş, M Erol, A Sari, H Kavgaci, F Öztuna, Ş Ersöz Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009 | 93 | 2009 |
| Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon city) C Erem, R Yildiz, H Kavgaci, C Karahan, O Deger, G Çan, M Telatar Diabetes research and clinical practice 54 (3), 203-208, 2001 | 91 | 2001 |
| The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study MN Yavuz, AA Yavuz, F Aydin, G Can, H Kavgaci International Journal of Radiation Oncology* Biology* Physics 54 (1), 195-202, 2002 | 89 | 2002 |
| Diagnostic and prognostic significance of CA IX and suPAR in gastric cancer E Fidan, A Mentese, F Ozdemir, O Deger, H Kavgaci, S Caner Karahan, ... Medical oncology 30, 1-5, 2013 | 56 | 2013 |
| Thrombin activatable fibrinolysis inhibitor and thrombin-antithrombin-III-complex levels in patients with gastric cancer E Fidan, H Kavgaci, A Orem, M Yilmaz, B Yildiz, S Fidan, B Akcan, ... Tumor Biology 33, 1519-1525, 2012 | 52 | 2012 |
| Is SCUBE 1 a new biomarker for gastric cancer? A Mentese, E Fidan, AU Sumer, SC Karahan, M Sonmez, DU Altay, ... Cancer Biomarkers 11 (5), 191-195, 2012 | 49 | 2012 |
| Increased ischemia-modified albumin levels in patients with gastric cancer E Fidan, A Mentese, H Kavgaci, A Orem, S Fidan, A Uzun, F Ozdemir, ... Neoplasma 59 (4), 393, 2012 | 48 | 2012 |
| The effects of VEGF and VEGFR-2 on survival in patients with gastric cancer F Ozdemir, R Akdogan, F Aydin, A Reis, H Kavgaci, S Gul, E Akdogan JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH 25 (1), 83, 2006 | 47 | 2006 |
| Correlation of serum IL-2, IL-6 and IL-10 levels with International Prognostic Index in patients with aggressive non-Hodgkin’s lymphoma F Aydin, M Yilmaz, F Özdemir, H Kavgaci, MN Yavuz, AA Yavuz American journal of clinical oncology 25 (6), 570-572, 2002 | 46 | 2002 |
| The effects of losartan and fosinopril in hypertensive type 2 diabetic patients H Kavgaci, A Sahin, HO Ersoz, C Erem, F Ozdemir Diabetes research and clinical practice 58 (1), 19-25, 2002 | 31 | 2002 |
| The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive Non-Hodgkin's Lymphoma (NHL). F Ozdemir, F Aydin, M Yilmaz, H Kavgaci, O Bektas, MN Yavuz, AA Yavuz Journal of experimental & clinical cancer research: CR 23 (3), 485-488, 2004 | 26 | 2004 |
| Elevated serum levels of SCUBE1, a marker for coagulation, in patients with breast cancer TO Topcu, H Kavgaci, F Ozdemir, A Aksoy, D Erdem, A Mentese, ... The Tohoku journal of experimental medicine 237 (2), 127-132, 2015 | 25 | 2015 |
| The effects of melatonin on human hepatoma (Hep G2) cell line F Ozdemir, O Deniz, K Kaynar, M Arslan, H Kavgaci, B Yildiz, F Aydin Bratisl Lek Listy 110 (5), 276-279, 2009 | 21 | 2009 |
| The effects of environmental and dietary factors on the development of gastric cancer M Karagulle, E Fidan, H Kavgaci, F Ozdemir Age 204, 0.886, 2014 | 20 | 2014 |
| Hodgkin’s disease and autoimmune hemolytic anemia: a case report F Ozdemir, M Yilmaz, R Akdogan, K Kaynar, H Kavgaci, S Karti, F Aydin Medical Principles and Practice 14 (3), 205-207, 2005 | 19 | 2005 |
| Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study. H Abali, I Celik, B Karaca, H Turna, T Akman, I Oztop, S Turhal, A Sezer, ... Journal of BU ON.: Official Journal of the Balkan Union of Oncology 20 (4 …, 2015 | 18 | 2015 |
| The clinical importance of serum galectin-3 levels in breast cancer patients with and without metastasis TO Topcu, H Kavgaci, M Gunaldi, H Kocoglu, M Akyol, A Mentese, ... Journal of Cancer Research and Therapeutics 14 (Suppl 3), S583-S586, 2018 | 17 | 2018 |
| Effects of dexamethasone, all-trans retinoic acid, vitamin D3 and interferon-α on FO myeloma cells F Ozdemir, N Esen, E Ovali, Y Tekelioglu, M Yilmaz, F Aydin, H Kavgaci, ... Chemotherapy 50 (4), 190-193, 2004 | 16 | 2004 |
| Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology A Bilici, T Ozturk, E Turkmen, H Odabas, S Cihan, F Selcukbiricik, ... World journal of urology 33, 1613-1622, 2015 | 15 | 2015 |
